Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieping Chen

Showing results (261-270 of 281) with videos related to

Pageof 29
Sort By:
Nature Medicine|March 6, 2019
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapyJun Wang, Jingwei Sun, Linda N Liu, et al.
Science Translational Medicine|December 13, 2019
PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosusXue Han, Matthew D Vesely, Wendy Yang, et al.
Journal of Neuroinflammation|October 25, 2008
Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infectionGretchen Hermes, James W Ajioka, Krystyna A Kelly, et al.
Cell|December 25, 2018
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3Jun Wang, Miguel F Sanmamed, Ila Datar, et al.
American Journal of Respiratory Cell and Molecular Biology|November 30, 2022
VISTA (PD-1H) Is a Crucial Immune Regulator to Limit Pulmonary FibrosisSang-Hun Kim, Taylor S Adams, Qianni Hu, et al.
Cancer Research|March 20, 2012
Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cellsMagali Terme, Evelyn Ullrich, Laetitia Aymeric, et al.
Nature Medicine|August 24, 2004
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalTyler J Curiel, George Coukos, Linhua Zou, et al.
Nature Medicine|April 22, 2003
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunityTyler J Curiel, Shuang Wei, Haidong Dong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlatesJulie R Brahmer, Charles G Drake, Ira Wollner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2023
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic CorrelatesJulie R Brahmer, Charles G Drake, Ira Wollner, et al.
Pageof 29

Showing results (261-270 of 281) with videos related to

Sort By:
Pageof 29
Nature Medicine|March 6, 2019
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapyJun Wang, Jingwei Sun, Linda N Liu, et al.
Science Translational Medicine|December 13, 2019
PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosusXue Han, Matthew D Vesely, Wendy Yang, et al.
Journal of Neuroinflammation|October 25, 2008
Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infectionGretchen Hermes, James W Ajioka, Krystyna A Kelly, et al.
Cell|December 25, 2018
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3Jun Wang, Miguel F Sanmamed, Ila Datar, et al.
American Journal of Respiratory Cell and Molecular Biology|November 30, 2022
VISTA (PD-1H) Is a Crucial Immune Regulator to Limit Pulmonary FibrosisSang-Hun Kim, Taylor S Adams, Qianni Hu, et al.
Cancer Research|March 20, 2012
Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cellsMagali Terme, Evelyn Ullrich, Laetitia Aymeric, et al.
Nature Medicine|August 24, 2004
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalTyler J Curiel, George Coukos, Linhua Zou, et al.
Nature Medicine|April 22, 2003
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunityTyler J Curiel, Shuang Wei, Haidong Dong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlatesJulie R Brahmer, Charles G Drake, Ira Wollner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2023
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic CorrelatesJulie R Brahmer, Charles G Drake, Ira Wollner, et al.
Pageof 29